MBRX

Moleculin Biotech, Inc.

Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company

Total Trades

10

Buys

8

Sells

0

Largest Trade

N/A

Insiders

3

Institutional Funds

12

Inst. Value

$100K–$500K

Activist Filings

5

Insider Trades

InsiderTitleTypeValueSharesPriceDate
Foster Jonathan P.CFOEXERCISEN/A7KJun 23, 2025
Foster Jonathan P.CFOBUY$50K–$100K270K$0.37Jun 23, 2025
KLEMP WALTER VCEO and PresidentBUY$100K–$500K676K$0.37Jun 23, 2025
KLEMP WALTER VCEO and PresidentEXERCISEN/A13KJun 23, 2025
Foster Jonathan P.CFOBUY$15K–$50K29K$0.69Dec 27, 2023
George Robert E.DirectorBUY$1K–$15K14K$0.69Dec 27, 2023
KLEMP WALTER VCEO and PresidentBUY$100K–$500K188K$0.69Dec 27, 2023
KLEMP WALTER VCEO and PresidentBUY$50K–$100K45K$1.28Nov 28, 2022
KLEMP WALTER VCEO and PresidentBUY$15K–$50K23K$1.15Nov 23, 2022
KLEMP WALTER VCEO and PresidentBUY$100K–$500K110K$0.98Nov 19, 2022
🔓Seeing ranges? Sign in for exact trade values — free forever

Institutional Ownership

13F filings as of Dec 31, 2025 · 12 funds holding

Activist & 5%+ Owners

SC 13D/13G filings — investors holding 5%+ of outstanding shares

Armistice Capital, LLC

SC 13G/A · Aug 15, 2025

5.0%

1.6M shares

Armistice Capital, LLC

SC 13G/A · May 15, 2025

8.9%

1.3M shares

Armistice Capital, LLC

SC 13G/A · Feb 14, 2025

10.0%

340K shares

Armistice Capital, LLC

SC 13G/A · Nov 14, 2024

10.0%

301K shares

Armistice Capital, LLC

SC 13G · Feb 14, 2024

10.0%

3.3M shares

View on Google Finance →